CAAS CAPITAL MANAGEMENT LP - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 421 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.

Quarter-by-quarter ownership
CAAS CAPITAL MANAGEMENT LP ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$23,315,200
+17.4%
179,929
+0.1%
1.41%
+47.6%
Q3 2022$19,868,000
+26.8%
179,734
-14.0%
0.96%
+22.1%
Q2 2022$15,671,000
-0.1%
209,060
+4.1%
0.78%
+21.2%
Q1 2022$15,686,000
-42.6%
200,800
-33.8%
0.64%
-3.2%
Q4 2021$27,324,000
-0.7%
303,430
+2.0%
0.67%
+20.9%
Q3 2021$27,508,000
+20.9%
297,444
+1.6%
0.55%
+43.9%
Q2 2021$22,758,000
+470.9%
292,744
+447.4%
0.38%
+790.7%
Q1 2021$3,986,000
-90.4%
53,478
-78.0%
0.04%
-89.1%
Q4 2020$41,429,000243,0000.40%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 112,689$14,541,00014.93%
Casdin Capital, LLC 670,000$86,457,0007.95%
Logos Global Management LP 226,002$29,163,0007.19%
Avoro Capital Advisors LLC 1,760,000$227,110,0006.67%
Camber Capital Management LP 600,000$77,424,0003.94%
STANSBERRY ASSET MANAGEMENT, LLC 71,133$9,179,0003.74%
Eventide Asset Management 996,000$128,524,0003.62%
CADIAN CAPITAL MANAGEMENT, LP 550,000$70,972,0003.14%
RTW INVESTMENTS, LP 605,762$78,168,0002.95%
Consonance Capital Management LP 356,145$45,957,0002.80%
View complete list of SAREPTA THERAPEUTICS INC shareholders